Predicting FVIII Activity in Patients Who Use Recombinant FVIII Fc Fusion Protein for Prophylaxis and Treatment of Bleeding Episodes
Blood - United States
doi 10.1182/blood.v124.21.1522.1522
Full Text
Open PDFAbstract
Available in full text
Date
December 6, 2014
Authors
Publisher
American Society of Hematology